Montelucaste Sandoz (Montelukast)

Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth‑muscle and inflammatory cells. By preventing leukotriene D4 from binding, it reduces bronchoconstriction, vascular leakage, and eosinophilic inflammation, which together improve breathing and lessen allergic symptoms.

The specific dose of Montelucaste Sandoz is determined by the prescribing clinician based on the patient’s age, condition severity, and treatment goals. Healthcare professionals follow approved labeling and clinical guidelines to set the appropriate regimen.

Safety data for montelukast in pregnancy and lactation are limited. Prescribers should weigh potential benefits against unknown risks and discuss them with the patient. If treatment is necessary, it should be used only under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients who need additional control of leukotriene‑driven inflammation, but it does not replace rescue bronchodilators for acute attacks.

Montelucaste Sandoz should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and discard any product that appears discoloured or damaged.

The medication is taken orally, usually once daily in the evening, with or without food. Patients should swallow the tablet whole and follow the prescriber’s instructions regarding timing and any concomitant therapies.

Serious adverse events, although rare, include neuropsychiatric reactions such as agitation, depression or suicidal thoughts, severe allergic responses like anaphylaxis, and liver injury indicated by elevated enzymes. Any of these symptoms warrant immediate medical evaluation.

Montelucaste Sandoz is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet’s excipients. Caution is advised for patients with severe hepatic impairment, and it should be used only under medical guidance during pregnancy or lactation.